National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2240) > Neoplasms (581) > Neoplasms by Site (431) >

Breast Neoplasms (71)

Narrow:

Breast Neoplasms, Male (3)
Carcinoma, Ductal, Breast (1)

41-60 of 71   < Previous | Next >
41.   Diagnosis of breast disease. 1994 Jan (revised 2012 Jan). NGC:008960 Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
42.   Early detection of cancers. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009647 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
43.   Genetic counselling and testing. In: Guidelines for preventive activities in general practice, 8th edition.2012. NGC:009640 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
44.   Preventive activities in middle age. In: Guidelines for preventive activities in general practice, 8th edition.2012. NGC:009642 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
45.   Screening tests of unproven benefit. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009653 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
46.   Recommendations on screening for breast cancer in average-risk women aged 40–74 years. 1994 Jan (revised 2011 Nov). NGC:009058 Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)  Compare Selected
47.   Position statement on screening mammography. 2011 Aug 15. NGC:009595 American Society of Breast Surgeons - Professional Association. View all guidelines by the developer(s) Compare Selected
48.   Breast cancer screening. 2003 Apr (revised 2011 Aug). NGC:008655 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s)  Compare Selected
49.   Risk reduction and surveillance strategies for individuals at high genetic risk for breast and ovarian cancer. 2011 Apr. NGC:009400 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
50.   American Society of Clinical Oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. 2000 Mar (revised 2011). NGC:008441 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
51.   ACR Appropriateness Criteria® conservative surgery and radiation—stage I and II breast carcinoma. 1996 (revised 2011). NGC:008468 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
52.   ACR Appropriateness Criteria® locally advanced breast cancer. 1996 (revised 2011). NGC:008469 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
53.   Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. 2011 Sep 1. NGC:009045 American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected
54.   The role of IMRT in breast cancer. 2010 Oct 27. NGC:008824 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
55.   Magnetic resonance imaging for breast cancer screening, pre-operative assessment, and follow-up. 2010 Oct (republished 2012 Jan). NGC:008706 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
56.   Breast cancer screening clinical practice guideline. 2010 Aug. NGC:008538 Kaiser Permanente Care Management Institute - Managed Care Organization. View all guidelines by thedeveloper(s)  Compare Selected
57.   Adjuvant ovarian ablation in the treatment of premenopausal women with early stage invasive breast cancer. 2010 Jul 6. NGC:009198 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
58.   American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. 2010 Apr. NGC:007851 American Society of Clinical Oncology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
59.   Cancer screening. 2010 Feb. NGC:009537 Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
60.   Zoledronic acid as adjuvant therapy in combination with adjuvant endocrine therapy for premenopausal women with early-stage hormone receptor positive breast cancer. 2010 Jan 25. NGC:007887 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)